These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24333591)

  • 1. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.
    Bana L; Minniti S; Salvati E; Sesana S; Zambelli V; Cagnotto A; Orlando A; Cazzaniga E; Zwart R; Scheper W; Masserini M; Re F
    Nanomedicine; 2014 Oct; 10(7):1583-90. PubMed ID: 24333591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease.
    Mancini S; Minniti S; Gregori M; Sancini G; Cagnotto A; Couraud PO; Ordóñez-Gutiérrez L; Wandosell F; Salmona M; Re F
    Nanomedicine; 2016 Jan; 12(1):43-52. PubMed ID: 26410276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide.
    Re F; Cambianica I; Sesana S; Salvati E; Cagnotto A; Salmona M; Couraud PO; Moghimi SM; Masserini M; Sancini G
    J Biotechnol; 2011 Dec; 156(4):341-6. PubMed ID: 21763360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease.
    Mancini S; Balducci C; Micotti E; Tolomeo D; Forloni G; Masserini M; Re F
    J Control Release; 2017 Jul; 258():121-129. PubMed ID: 28501671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer's disease.
    Forcaia G; Formicola B; Terribile G; Negri S; Lim D; Biella G; Re F; Moccia F; Sancini G
    Mol Neurobiol; 2021 Jun; 58(6):2824-2835. PubMed ID: 33511502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.
    Salvati E; Re F; Sesana S; Cambianica I; Sancini G; Masserini M; Gregori M
    Int J Nanomedicine; 2013; 8():1749-58. PubMed ID: 23674890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.
    Taylor M; Moore S; Mourtas S; Niarakis A; Re F; Zona C; La Ferla B; Nicotra F; Masserini M; Antimisiaris SG; Gregori M; Allsop D
    Nanomedicine; 2011 Oct; 7(5):541-50. PubMed ID: 21722618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.
    Balducci C; Mancini S; Minniti S; La Vitola P; Zotti M; Sancini G; Mauri M; Cagnotto A; Colombo L; Fiordaliso F; Grigoli E; Salmona M; Snellman A; Haaparanta-Solin M; Forloni G; Masserini M; Re F
    J Neurosci; 2014 Oct; 34(42):14022-31. PubMed ID: 25319699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration.
    Kuo YC; Chen CL; Rajesh R
    Acta Biomater; 2019 Mar; 87():207-222. PubMed ID: 30716553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma.
    Poduslo JF; Curran GL; Kumar A; Frangione B; Soto C
    J Neurobiol; 1999 Jun; 39(3):371-82. PubMed ID: 10363910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetratin Peptide-Functionalized Gold Nanostars: Enhanced BBB Permeability and NIR Photothermal Treatment of Alzheimer's Disease Using Ultralow Irradiance.
    Yin T; Xie W; Sun J; Yang L; Liu J
    ACS Appl Mater Interfaces; 2016 Aug; 8(30):19291-302. PubMed ID: 27411476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescuing cholinergic neurons from apoptotic degeneration by targeting of serotonin modulator-and apolipoprotein E-conjugated liposomes to the hippocampus.
    Kuo YC; Lee YJ
    Int J Nanomedicine; 2016; 11():6809-6824. PubMed ID: 28008255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide.
    Gobbi M; Re F; Canovi M; Beeg M; Gregori M; Sesana S; Sonnino S; Brogioli D; Musicanti C; Gasco P; Salmona M; Masserini ME
    Biomaterials; 2010 Sep; 31(25):6519-29. PubMed ID: 20553982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting delivery of liposomes with conjugated p-aminophenyl-α-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptide.
    Kuo YC; Lin CY
    J Drug Target; 2015 Feb; 23(2):147-58. PubMed ID: 25268274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of Alzheimer's disease.
    Binda A; Panariti A; Barbuti A; Murano C; Dal Magro R; Masserini M; Re F; Rivolta I
    Int J Nanomedicine; 2018; 13():4059-4071. PubMed ID: 30034232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease.
    Conti E; Gregori M; Radice I; Da Re F; Grana D; Re F; Salvati E; Masserini M; Ferrarese C; Zoia CP; Tremolizzo L
    Neurochem Int; 2017 Sep; 108():60-65. PubMed ID: 28238790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB.
    Formicola B; Dal Magro R; Montefusco-Pereira CV; Lehr CM; Koch M; Russo L; Grasso G; Deriu MA; Danani A; Bourdoulous S; Re F
    J Nanobiotechnology; 2019 Nov; 17(1):115. PubMed ID: 31711496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
    Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.